We are live on
!
Find out more
BCIM
British Columbia Investment Management Portfolio holdings
AUM
$17B
1-Year Est. Return
31.69%
This Fund
S&P 500
This Quarter
Est. Return
+1.75%
1 Year Est. Return
+31.69%
3 Year Est. Return
+89.35%
5 Year Est. Return
+112.26%
10 Year Est. Return
+424.53%
AUM
$11.1B
AUM Growth
-$1.04B
(-8.6%)
Cap. Flow
-$1.11B
Cap. Flow
% of AUM
-10.03%
Top 10 Holdings %
Top 10 Hldgs %
15.54%
Holding
812
New
29
Increased
252
Reduced
388
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$27.8M |
| 3 |
Medtronic
MDT
|
+$17.5M |
| 4 |
General Motors
GM
|
+$14.8M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$78M |
| 2 |
Canadian National Railway
CNI
|
+$41.5M |
| 3 |
Brookfield
BN
|
+$40M |
| 4 |
Suncor Energy
SU
|
+$37.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$34.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.55% |
| 2 | Technology | 15.47% |
| 3 | Financials | 14.56% |
| 4 | Industrials | 10.27% |
| 5 | Consumer Staples | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.57T
| $363M | 3.27% |
11,659,580
-672,768
| -5% | -$20.3M |
|
|
2
Alphabet (Google) Class C
GOOG
$4.32T
| $215M | 1.94% |
7,813,834
-1,296,169
| -14% | -$34.7M |
|
|
3
Johnson & Johnson
JNJ
$625B
| $179M | 1.61% |
1,774,482
+140,511
| +9% | +$14.3M |
|
4
ExxonMobil
XOM
$634B
| $177M | 1.6% |
2,085,609
-144,011
| -6% | -$12.8M |
|
5
Microsoft
MSFT
$3.71T
| $156M | 1.4% |
3,825,123
-178,302
| -4% | -$7.76M |
|
6
Procter & Gamble
PG
$339B
| $135M | 1.22% |
1,643,720
-377,541
| -19% | -$32.5M |
|
7
Wells Fargo
WFC
$264B
| $127M | 1.14% |
2,326,896
-142,901
| -6% | -$7.72M |
|
8
Verizon
VZ
$196B
| $126M | 1.14% |
2,593,368
-544,787
| -17% | -$26.3M |
|
9
Berkshire Hathaway Class B
BRK.B
$1.13T
| $124M | 1.12% |
858,515
+33,187
| +4% | +$4.88M |
|
10
GE Aerospace
GE
$384B
| $121M | 1.1% |
1,021,442
-60,449
| -6% | -$7.2M |
|
11
JPMorgan Chase
JPM
$950B
| $112M | 1.01% |
1,843,614
-125,572
| -6% | -$7.44M |
|
12
Merck
MRK
$318B
| $104M | 0.94% |
1,889,272
-402,734
| -18% | -$22.8M |
|
13
Pfizer
PFE
$153B
| $101M | 0.92% |
3,071,114
-325,753
| -10% | -$10.4M |
|
14
Chevron
CVX
$366B
| $100M | 0.91% |
955,601
-14,814
| -2% | -$1.58M |
|
15
Gilead Sciences
GILD
$165B
| $97M | 0.88% |
988,649
-227,197
| -19% | -$23.1M |
|
16
Oracle
ORCL
$423B
| $92.3M | 0.83% |
2,137,991
-233,481
| -10% | -$10.1M |
|
17
PepsiCo
PEP
$190B
| $91.7M | 0.83% |
959,522
-181,726
| -16% | -$17.6M |
|
18
Meta Platforms (Facebook)
META
$1.51T
| $89.9M | 0.81% |
1,093,104
-52,365
| -5% | -$4.1M |
|
19
Walt Disney
DIS
$181B
| $88.4M | 0.8% |
842,778
-32,860
| -4% | -$3.32M |
|
20
Intel
INTC
$513B
| $88M | 0.79% |
2,814,311
-1,029,041
| -27% | -$34.7M |
|
21
IBM
IBM
$224B
| $87.7M | 0.79% |
571,834
-119,416
| -17% | -$18.1M |
|
|
AGN
22
DELISTED
Allergan plc
AGN
| $85.6M | 0.77% |
287,585
+164,683
| +134% | +$47M |
|
23
Bank of America
BAC
$442B
| $81.6M | 0.74% |
5,300,181
-158,206
| -3% | -$2.54M |
|
24
Citigroup
C
$226B
| $78.8M | 0.71% |
1,529,757
-30,697
| -2% | -$1.56M |
|
25
Amgen
AMGN
$222B
| $78.5M | 0.71% |
490,923
-85,444
| -15% | -$13.5M |
|
Similar funds
VMPIC
PP
ASRS
CM
CI
EIP
BBA
British Columbia Investment Management's Q1 2015 Portfolio in Review
As of Q1 2015, British Columbia Investment Management held 812 positions worth $11.1B, down 8.6% from $12.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
British Columbia Investment Management withdrew a net $1.11B in Q1 2015, closing 99 positions and reducing 388 holdings. Its most notable exit was Allergan Inc, an estimated $78M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, British Columbia Investment Management opened a new position in Stratasys worth $2.64M.
- British Columbia Investment Management's largest Q1 2015 buy was Stratasys: 50,000 shares worth $2.64M.
- British Columbia Investment Management added most to Allergan plc in Q1 2015, an estimated $47M increase.
- British Columbia Investment Management's biggest Q1 2015 reduction was Canadian National Railway, cutting an estimated $41.5M.
- British Columbia Investment Management fully exited Allergan Inc in Q1 2015, selling an estimated $78M.
- British Columbia Investment Management's ten largest holdings make up 16% of its $11.1B portfolio in Q1 2015.
- British Columbia Investment Management opened 29 new positions and closed 99 in Q1 2015.
- British Columbia Investment Management's portfolio value fell 8.6% quarter-over-quarter to $11.1B.
Based on British Columbia Investment Management's 13F filing for Q1 2015, filed 5 May 2015.